SureTrader Advertisement SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, Doubledown22, Stock Barber, baryoboy, KBing617
Search This Board:
Last Post: 4/29/2016 11:18:38 AM - Followers: 467 - Board type: Free - Posts Today: 36


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#102976  Sticky Note Link to EP Global Communications 4/28/16 Conference call; flaflyersfan 04/29/16 10:15:58 AM
#100372  Sticky Note $EPGL Facts- Published Patent Apps, Tweets, Pictures, Confirmations vikingzskillz 03/31/16 09:28:02 AM
#97811  Sticky Note EP Global Communications, Inc. Reaches Settlement Agreement with vikingzskillz 02/09/16 02:25:24 PM
#95482  Sticky Note Press releases or other company communication should not IH Admin [Brian] 01/12/16 12:14:18 PM
#102991   What you say is so obvious. I would franck92 04/29/16 11:18:38 AM
#102990   The song of EPgl to his shareholders franck92 04/29/16 11:11:30 AM
#102989   You should care if J&J issues a public skorz 04/29/16 11:10:37 AM
#102988   Excellent CC! Shotime66 04/29/16 10:51:11 AM
#102987   I think if JNJ puts out a PR TexAg2006 04/29/16 10:50:37 AM
#102986   Those with reasonable expectations never anticipated a big Squeejo 04/29/16 10:47:33 AM
#102985   I dont care a PR from J&J, I franck92 04/29/16 10:47:26 AM
#102984   The fundamentals are here = franck92 04/29/16 10:46:05 AM
#102983   i think the issue is they are not Conlan1 04/29/16 10:42:20 AM
#102982   Soon we will know the results of the franck92 04/29/16 10:36:22 AM
#102981   Looks like those expecting a rise are going Volcanridge 04/29/16 10:36:07 AM
#102980   I did my contribution slapping the ask's early cheeva_pitt 04/29/16 10:31:58 AM
#102979   The next PR will accomplish that, imo. wobblenuts 04/29/16 10:26:46 AM
#102977   It will happen Charlie , hang in there!! Squeejo 04/29/16 10:15:58 AM
#102976   Link to EP Global Communications 4/28/16 Conference call; flaflyersfan 04/29/16 10:15:58 AM
#102974   Yes, but where is all the BUYING?? CancunCharlie 04/29/16 10:07:42 AM
#102973   Looks like those expecting a sell off that Squeejo 04/29/16 10:02:15 AM
#102972   $EPGL DD SHEET ** Johnson & Johnson EXCLUSIVE vikingzskillz 04/29/16 09:24:45 AM
#102971   What VikingzSkills (thank you David) Said -> CC: MDP Holdings LLP 04/29/16 09:14:53 AM
#102970   Time to ramp up accumulation, I feel a vikingzskillz 04/29/16 09:06:23 AM
#102969   Callers where piling in even after start time! $EPGL vikingzskillz 04/29/16 09:04:36 AM
#102968   Conf Call: Professional, Authentic, Exciting! I got on MDP Holdings LLP 04/29/16 09:03:15 AM
#102967   Great CC.... Eager to see what happens next!!! Gatsby 04/29/16 08:57:19 AM
#102966   Thanks to David for uploading to YouTube. $EPGL vikingzskillz 04/29/16 08:49:36 AM
#102965   $EPGL Conference Call 4/28/2016, posted on Facebook will vikingzskillz 04/29/16 08:45:46 AM
#102964   Very important aspect = franck92 04/29/16 08:41:38 AM
#102963   It seems it takes 26 months in average franck92 04/29/16 08:40:26 AM
#102962   The cc was concise and the most professional CommonVestor 04/29/16 07:48:48 AM
#102961   Today will show if cc call listeners buy flaflyersfan 04/29/16 07:24:28 AM
#102960   140 people were on last evening's conference call vikingzskillz 04/29/16 07:09:11 AM
#102959   I was 9 minutes late to the call willy1_12 04/29/16 04:13:59 AM
#102958   I'd be surprised if the PPS doesn't move Mrzach3590 04/29/16 02:25:56 AM
#102957   Conference call was professional and to the point. Promising WhymeMA 04/29/16 12:56:09 AM
#102956   Now that I can post again I can franck92 04/29/16 12:19:16 AM
#102955   Great wasn't it! vikingzskillz 04/28/16 11:55:36 PM
#102954   Hayes sounded incredibly confident about the patents. Valiant 04/28/16 11:47:35 PM
#102953   Out of EPGLs control!!! gman22 04/28/16 11:43:59 PM
#102952   I was unsure what to expect this CC AnuT 04/28/16 10:38:56 PM
#102951   EPGL! I am now a believer. A very cstutz 04/28/16 10:27:19 PM
#102949   The pieces of this puzzle are falling precisely Shotime66 04/28/16 10:19:20 PM
#102948   Agreed, when I came on at 8:59 there DBS 04/28/16 10:18:39 PM
#102947   Thanks Vike and others. I'll get your consolidated Doubledown22 04/28/16 10:15:31 PM
#102946   The TRUTH!!! Shotime66 04/28/16 10:14:41 PM
#102945   Those would be the ones....from the way he Doubledown22 04/28/16 10:11:00 PM
#102944   Great CC! The future is brighter than ever. Mrzach3590 04/28/16 10:08:06 PM
#102943   You are very welcome JudyPudy and WobbleNuts. I Doubledown22 04/28/16 09:56:48 PM
#102942   He sounded very serious and focused during the 4u2nv2 04/28/16 09:56:28 PM
#102941   Very serious and impressive, big things in the works!! vikingzskillz 04/28/16 09:54:43 PM
#102940   Thanks for posting details DoubleD, best mod here vikingzskillz 04/28/16 09:53:59 PM
#102939   Yes, very nice $EPGL vikingzskillz 04/28/16 09:52:04 PM